Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Treat-and-repair strategy is a feasible therapeutic choice in adult patients with severe pulmonary arterial hypertension associated with a ventricular septal defect: case series.

Akagi S, Kasahara S, Sarashina T, Nakamura K, Ito H.

Eur Heart J Case Rep. 2018 Mar 22;2(2):yty033. doi: 10.1093/ehjcr/yty033. eCollection 2018 Jun.

2.

Successful Transition from Phosphodiesterase-5 Inhibitors to Riociguat Without a Washout Period in Patients With Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: A Pilot Cohort Study.

Kuroda K, Akagi S, Nakamura K, Sarashina T, Ejiri K, Ito H.

Heart Lung Circ. 2019 Feb 7. pii: S1443-9506(19)30048-4. doi: 10.1016/j.hlc.2019.01.013. [Epub ahead of print]

PMID:
30773322
3.

Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension.

Nakamura K, Sakaguchi M, Matsubara H, Akagi S, Sarashina T, Ejiri K, Akazawa K, Kondo M, Nakagawa K, Yoshida M, Miyoshi T, Ogo T, Oto T, Toyooka S, Higashimoto Y, Fukami K, Ito H.

PLoS One. 2018 Sep 4;13(9):e0203046. doi: 10.1371/journal.pone.0203046. eCollection 2018.

4.

Progression of pulmonary artery dilatation in patients with pulmonary hypertension coexisting with a pulmonary artery aneurysm.

Akagi S, Nakamura K, Sarashina T, Ejiri K, Kasahara S, Ito H.

J Cardiol. 2018 May;71(5):517-522. doi: 10.1016/j.jjcc.2017.11.005. Epub 2017 Dec 13.

5.

Suppression of Wnt Signaling and Osteogenic Changes in Vascular Smooth Muscle Cells by Eicosapentaenoic Acid.

Saito Y, Nakamura K, Miura D, Yunoki K, Miyoshi T, Yoshida M, Kawakita N, Kimura T, Kondo M, Sarashina T, Akagi S, Watanabe A, Nishii N, Morita H, Ito H.

Nutrients. 2017 Aug 10;9(8). pii: E858. doi: 10.3390/nu9080858.

6.

High Frequency of Acute Adverse Cardiovascular Events After Lung Transplantation in Patients With Pulmonary Arterial Hypertension Receiving Preoperative Long-Term Intravenous Prostacyclin.

Akagi S, Oto T, Kobayashi M, Miyoshi K, Sugimoto S, Yamane M, Nakamura K, Sarashina T, Miyoshi S, Ito H.

Int Heart J. 2017 Aug 3;58(4):557-561. doi: 10.1536/ihj.16-389. Epub 2017 Jul 10.

7.

Nanoparticle-Mediated Drug Delivery System for Pulmonary Arterial Hypertension.

Nakamura K, Matsubara H, Akagi S, Sarashina T, Ejiri K, Kawakita N, Yoshida M, Miyoshi T, Watanabe A, Nishii N, Ito H.

J Clin Med. 2017 Apr 29;6(5). pii: E48. doi: 10.3390/jcm6050048. Review.

8.

Effects of reduction of pressure overload on right ventricular function in patients with Eisenmenger syndrome.

Nakamura K, Sarashina T, Ejiri K, Akagi S.

J Cardiol. 2017 May;69(5):739-740. doi: 10.1016/j.jjcc.2017.02.002. Epub 2017 Mar 17. No abstract available.

9.

Enhanced EP4 Expression in a Pulmonary Artery Aneurysm With Dissection in a Patient With Pulmonary Arterial Hypertension.

Akagi S, Nakamura K, Yokoyama U, Kasahara S, Sarashina T, Ejiri K, Ito H.

Circ Cardiovasc Imaging. 2017 Feb;10(2). pii: e005839. doi: 10.1161/CIRCIMAGING.116.005839. No abstract available.

PMID:
28108433
10.

Reverse Right Ventricular Remodeling After Lung Transplantation in Patients With Pulmonary Arterial Hypertension Under Combination Therapy of Targeted Medical Drugs.

Sarashina T, Nakamura K, Akagi S, Oto T, Oe H, Ejiri K, Nakagawa K, Nishii N, Matsubara H, Kobayashi M, Morimatsu H, Miyoshi S, Ito H.

Circ J. 2017 Feb 24;81(3):383-390. doi: 10.1253/circj.CJ-16-0838. Epub 2017 Jan 18.

12.

Epoprostenol Therapy for Pulmonary Arterial Hypertension.

Akagi S, Nakamura K, Matsubara H, Ogawa A, Sarashina T, Ejiri K, Ito H.

Acta Med Okayama. 2015;69(3):129-36. Review.

13.

Epoprostenol sodium for treatment of pulmonary arterial hypertension.

Saito Y, Nakamura K, Akagi S, Sarashina T, Ejiri K, Miura A, Ogawa A, Matsubara H, Ito H.

Vasc Health Risk Manag. 2015 May 14;11:265-70. doi: 10.2147/VHRM.S50368. eCollection 2015. Review.

14.

Histological changes of pulmonary arteries treated by balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension.

Kitani M, Ogawa A, Sarashina T, Yamadori I, Matsubara H.

Circ Cardiovasc Interv. 2014 Dec;7(6):857-9. doi: 10.1161/CIRCINTERVENTIONS.114.001533. No abstract available.

PMID:
25516761
15.

[Treatment with imatinib for refractory PAH].

Nakamura K, Akagi S, Sarashina T, Ogawa A, Matsubara H, Ito H.

Nihon Yakurigaku Zasshi. 2014 Apr;143(4):173-7. Review. Japanese. No abstract available.

PMID:
24717604
16.

Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation – the J-ROCKET AF study –.

Hori M, Matsumoto M, Tanahashi N, Momomura S, Uchiyama S, Goto S, Izumi T, Koretsune Y, Kajikawa M, Kato M, Ueda H, Iwamoto K, Tajiri M; J-ROCKET AF study investigators.

Circ J. 2012;76(9):2104-11. Epub 2012 Jun 5.

Supplemental Content

Loading ...
Support Center